LeonaBio (LONA) Invested Capital (2019 - 2026)

LeonaBio (LONA) has 8 years of Invested Capital data on file, last reported at $49.3 million in Q1 2026.

• Invested Capital for Q1 2026 came in at $49.3 million, up 32.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $49.3 million (up 32.07% YoY), and the FY2025 annual result was $27.8 million, down 38.03% from the prior year.
• Invested Capital grew to $49.3 million in Q1 2026 per LONA's latest filing, from $27.8 million in the prior quarter.
• Over five years, Invested Capital peaked at $302.0 million in Q1 2022 and troughed at $26.8 million in Q3 2025.
• A 5-year average of $131.0 million and a median of $106.7 million in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2024 and 2026: Invested Capital sank 65.56% in 2024, then jumped 32.07% in 2026.
• A 5-year view of Invested Capital shows it stood at $235.1 million in 2022, then tumbled by 44.63% to $130.2 million in 2023, then slumped by 65.56% to $44.8 million in 2024, then tumbled by 38.03% to $27.8 million in 2025, then soared by 77.41% to $49.3 million in 2026.
• Business Quant data shows LONA's Invested Capital at $49.3 million in Q1 2026, $27.8 million in Q4 2025, and $26.8 million in Q3 2025.